Filed Pursuant to Rule 424(b)(3)
                                                              File No. 333-95321
PROSPECTUS SUPPLEMENT NO. 1
(to Prospectus Dated January 24, 2000)


                               [LOGO OF VIDAMED]

                        8,740,000 Shares of Common Stock

                 2,090,320 Shares of Common Stock to be Issued
                   Upon the Exercise of Outstanding Warrants

                              ___________________


     This Prospectus Supplement No. 1 supplements the prospectus dated January
24, 2000 relating to the 8,740,000 shares of common stock of VidaMed, Inc. and
2,090,320 shares of common stock of VidaMed, Inc. to be issued upon the exercise
of outstanding warrants, that may be offered for sale for the account of several
stockholders of VidaMed, their respective donees or pledgees, as stated under
the heading "Plan of Distribution" in the original prospectus.

     This Prospectus Supplement No. 1 is being filed to update the table of
Selling Stockholders in the original prospectus with respect to a change in
beneficial ownership that has occurred since the date of the  original
prospectus.  This Prospectus Supplement No. 1 is not complete without, and may
not be delivered or utilized except in connection with, the original prospectus.
This Prospectus Supplement No. 1 is qualified by reference to the original
prospectus, except to the extent that the information contained in this
Prospectus Supplement No. 1 supersedes the information contained in the original
prospectus.

                              SELLING STOCKHOLDERS

     The table of selling stockholders in the original prospectus lists
Medtronic Asset Management, Inc. as the beneficial owner of 6,890,000 shares of
VidaMed common stock, all of which were offered for sale pursuant to the
original prospectus.  On April 26, 2001, Medtronic Asset Management, Inc. made a
gift of a warrant to purchase 1,590,000 shares of VidaMed common stock to The
Medtronic Foundation.  Since the date of the original prospectus, Medtronic
Asset Management, Inc. has also purchased additional shares of VidaMed common
stock.  Accordingly, the table of Selling Stockholders as it relates to the
shares of VidaMed common stock listed as held by Medtronic Asset Management,
Inc. in the original prospectus is updated through October 15, 2001 and amended
to reflect the foregoing as follows:



                                      Shares Beneficially Owned            Shares Beneficially Owned
                                         Before the Offering     Shares       After the Offering
Name of                               -------------------------   Being    -------------------------
Beneficial Owner                         Number   Percentage     Offered    Number      Percentage
------------------------------------  ----------- ------------- ---------  -------    --------------
                                                                       
Medtronic Asset Management, Inc. (1)    6,100,000    17.0%      5,300,000  800,000       2.2%
The Medtronic Foundation (2)........    1,590,000     4.2%      1,590,000        0         0

__________________


(1) Based on a Schedule 13D/A filed with the Securities and Exchange Commission
    on May 24, 2001 and other information known to VidaMed.  Medtronic Asset
    Management, Inc. is a wholly owned subsidiary of Medtronic, Inc. through
    which Medtronic, Inc. holds investments.   Does not include shares
    beneficially owned by Michael D. Ellwein, a director of VidaMed, and Vice
    President and Chief Development Officer of Medtronic, Inc. or The Medtronic
    Foundation.  Pursuant to the terms of its initial investment in January
    2000, Medtronic has the right to designate one person for election to our
    board of directors, and Mr. Ellwein is Medtronic's designee.  The address of
    Medtronic Asset Management, Inc. is 710 Medtronic Parkway N.E., Minneapolis,
    Minnesota 55432.

(2) Shares beneficially owned by The Medtronic Foundation represent shares
    issuable upon exercise of a warrant and do not include any shares
    beneficially owned Medtronic Asset Management, Inc.  The address of The
    Medtronic Foundation is 710 Medtronic Parkway N.E., Minneapolis, Minnesota
    55432.


                              ___________________


     Neither the Securities and Exchange Commission nor any state securities
commission has approved or disapproved of these securities or determined if this
prospectus is truthful or complete.  Any representation to the contrary is a
criminal offense.

                              ___________________


           This Prospectus Supplement No. 1 is dated October 16, 2001

                                     II-2